Literature DB >> 21161325

Letter to the editor: "Phase II trial of S-1 monotherapy in elderly or frail patients with metastatic colorectal cancer".

M J Molina-Garrido, Carmen Guillén-Ponce.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21161325     DOI： 10.1007/s10637-010-9617-x

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN： 0167-6997            Impact factor:   3.850


× No keyword cloud information.
  11 in total

Review 1.  Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care.

Authors:  Linda P Fried; Luigi Ferrucci; Jonathan Darer; Jeff D Williamson; Gerard Anderson
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2004-03       Impact factor: 6.053

2.  [Decision making in geriatric oncology].

Authors:  Elisabeth Castel-Kremer; Jean-Pierre Droz
Journal:  Rev Prat       Date:  2009-03-20

3.  How and why to perform a geriatric assessment in clinical practice.

Authors:  C Terret
Journal:  Ann Oncol       Date:  2008-09       Impact factor: 32.976

4.  A controlled trial of inpatient and outpatient geriatric evaluation and management.

Authors:  Harvey Jay Cohen; John R Feussner; Morris Weinberger; Molly Carnes; Ronald C Hamdy; Frank Hsieh; Ciaran Phibbs; Donald Courtney; Kenneth W Lyles; Conrad May; Cynthia McMurtry; Leslye Pennypacker; David M Smith; Nina Ainslie; Thomas Hornick; Kayla Brodkin; Philip Lavori
Journal:  N Engl J Med       Date:  2002-03-21       Impact factor: 91.245

5.  Are frailty markers useful for predicting treatment toxicity and mortality in older newly diagnosed cancer patients? Results from a prospective pilot study.

Authors:  Martine T E Puts; Johanne Monette; Veronique Girre; Carmela Pepe; Michele Monette; Sarit Assouline; Lawrence Panasci; Mark Basik; Wilson H Miller; Gerald Batist; Christina Wolfson; Howard Bergman
Journal:  Crit Rev Oncol Hematol       Date:  2010-05-04       Impact factor: 6.312

6.  Comprehensive geriatric assessment: a meta-analysis of controlled trials.

Authors:  A E Stuck; A L Siu; G D Wieland; J Adams; L Z Rubenstein
Journal:  Lancet       Date:  1993-10-23       Impact factor: 79.321

7.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

Review 8.  Comprehensive geriatric assessment.

Authors:  Darryl Wieland; Victor Hirth
Journal:  Cancer Control       Date:  2003 Nov-Dec       Impact factor: 3.302

9.  Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma.

Authors:  Robert J Motzer; Jennifer Bacik; Lawrence H Schwartz; Victor Reuter; Paul Russo; Stephanie Marion; Madhu Mazumdar
Journal:  J Clin Oncol       Date:  2004-02-01       Impact factor: 44.544

10.  Usefulness of frailty markers in the assessment of the health and functional status of older cancer patients referred for chemotherapy: a pilot study.

Authors:  Frederique Retornaz; Johanne Monette; Gerald Batist; Michèle Monette; Nadia Sourial; David Small; Stephen Caplan; Doreen Wan-Chow-Wah; Martine T E Puts; Howard Bergman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-05       Impact factor: 6.053
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.